Nutrifoods Ghana Limited has been ordered to suspend the manufacture of its Tasty Tom Enriched Tomato Mix after the Food and Drugs Authority (FDA) uncovered serious violations at the company’s production site. The regulatory action comes after growing consumer complaints and a detailed inspection that revealed lapses compromising product safety and quality.
In a statement released on August 3, the FDA disclosed that its investigations found critical flaws in the manufacturing process. “Maintenance of critical manufacturing equipment was poor, and monitoring systems were inadequate to protect public health and safety,” the Authority stated.
The inspection revealed that defective sealing processes had exposed the tomato mix—particularly in pouches—to contamination, resulting in bloating. Some packages even showed signs of mold growth.
“Mold was found on some of them, raising serious health and safety concerns, hence the suspension and product recall,” the FDA explained.
As a result, the FDA has initiated a full market recall of Tasty Tom Enriched Tomato Mix in all canned forms, along with selected pouch sizes—specifically the 380g and 1.05kg variants.
Earlier, on August 1, Nutrifoods Ghana Limited had begun pulling these products from shelves following consultations with the FDA and National Security. The recall covered all batches of the 210g and 400g canned products and the affected pouches.
Jay Jagadip, Business Head of Nutrifoods Ghana Limited, acknowledged that the company had already been instructed by the FDA in January 2025 to halt production of the 210g and 400g canned tomato mix. Since then, manufacturing of those sizes has not resumed.
The company has now suspended all operations related to the product and is working to meet regulatory requirements. Customers have been encouraged to return any potentially affected products.
“Moreover, if you have any of the Tasty Tom Enriched Tomato Mix that you suspect may be affected, please return them to the above locations or contact the above number as well,” the company advised.
In a statement, the company apologized to customers and assured them of its commitment to resolving the issue.
“We deeply regret any inconvenience caused to our consumers and trade partners because of this issue and recall. We at Nutrifoods Ghana Ltd are committed to delivering high quality products meeting all the required stringent national food safety standards and ensure our consumers are delighted with our products. We want to reassure our consumers and trade partners that we are doing our best to recover all affected products and replace them without difficulty,” said Jagadip.
Meanwhile, the FDA has launched internal reviews to determine whether regulatory oversights contributed to the issue, particularly since the company had already been flagged in January.
The Authority emphasized its commitment to accountability. “Any dereliction of duty identified will be swiftly dealt with in order to strengthen the FDA’s regulatory oversight,” the statement noted.
The FDA also urged the general public, wholesalers, and retailers to take note of the suspension and cooperate with the recall process.
“We will continue to exercise rigorous oversight in accordance with our mandate to protect public health and safety,” the Authority assured.
Established in 1992 under the Food and Drug Law (PNDCL 305B), the FDA is Ghana’s primary regulator for food, drugs, cosmetics, tobacco products, household chemicals, and medical devices. It operates under the revised Public Health Act, 2012 (Act 851), and is also responsible for approving clinical trials and enforcing tobacco control regulations.
The FDA says its mission is to protect the health and safety of the Ghanaian public and to become a globally recognized authority in food and medical product regulation.
